| __timestamp | Sarepta Therapeutics, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 94231000 | 15635076 |
| Thursday, January 1, 2015 | 146394000 | 23943601 |
| Friday, January 1, 2016 | 188272000 | 23689111 |
| Sunday, January 1, 2017 | 166707000 | 41006114 |
| Monday, January 1, 2018 | 401843000 | 51379106 |
| Tuesday, January 1, 2019 | 560909000 | 32705593 |
| Wednesday, January 1, 2020 | 722343000 | 53274000 |
| Friday, January 1, 2021 | 771182000 | 85352000 |
| Saturday, January 1, 2022 | 877090000 | 51999000 |
| Sunday, January 1, 2023 | 877387000 | 59471000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Sarepta Therapeutics, Inc. has consistently outpaced Summit Therapeutics Inc. in R&D investments. From 2014 to 2023, Sarepta's R&D expenses surged by over 830%, peaking in 2023 with a staggering 878 million dollars. In contrast, Summit's R&D spending grew by approximately 280%, reaching nearly 59 million dollars in the same year. This significant disparity highlights Sarepta's aggressive pursuit of cutting-edge therapies, while Summit adopts a more conservative approach. As the biotech landscape evolves, these spending patterns may influence their respective positions in the market, with Sarepta potentially leading the charge in groundbreaking treatments.
Research and Development: Comparing Key Metrics for BeiGene, Ltd. and Summit Therapeutics Inc.
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Summit Therapeutics Inc.
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Sarepta Therapeutics, Inc.
Summit Therapeutics Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Summit Therapeutics Inc. or ACADIA Pharmaceuticals Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Summit Therapeutics Inc. vs ImmunityBio, Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Soleno Therapeutics, Inc.
R&D Spending Showdown: Summit Therapeutics Inc. vs Iovance Biotherapeutics, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Halozyme Therapeutics, Inc.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
R&D Insights: How Sarepta Therapeutics, Inc. and Galapagos NV Allocate Funds